Meet Phat Le, M.D.
Phat Le, M.D.
Department of General Oncology, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of General Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Associate Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2009 | UT Southwestern Medical School, Dallas, TX, USA, MD, Medicine |
| 2005 | University of Texas at Austin, Austin, TX, USA, BS, Microbiology |
Postgraduate Training
| 2012-2015 | Clinical Fellowship, Hematology/Oncology, UT Southwestern Medical Center, Dallas, TX |
| 2009-2012 | Clinical Residency, UT Southwestern Medical Center, Dallas, TX |
Board Certifications
| 2015 | American Board of Internal Medicine - Hematology |
| 2012 | American Board of Internal Medicine |
| 2012 | American Board of Internal Medicine - Medical Oncology |
Experience & Service
Academic Appointments
Assistant Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2022
Medical Oncology Lead, Department of General Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center Sugarland Houston Area Location, Sugar Land, TX, 2018 - Present
Assistant Professor, Department of General Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2022
Administrative Appointments/Responsibilities
Houston Methodist Cancer Center EPIC Validation Committee Member, Houston Methodist Hospital, Houston, TX, 2015 - Present
Medical Director, Department of Houston Methodist West Hospital Infusion Clinic, Houston Methodist West Hospital, Houston, TX, 2015 - Present
Cancer Committee member, Houston Methodist West Hospital, Houston, TX, 2015 - Present
Honors & Awards
| 2018 | Top 1% Provider, Clinician and Group Consumer Assessment of Healthcare Providers and Systems |
| 2014 | UT Southwestern Hematology/Oncology Chief Fellow |
| 2014 | Hematology/Oncology Academic Achievement awarded to the fellow with the highest score on the annual ASCO in-service exam, UT Southwestern |
| 2011 | Parkland Hospital Employee of the Month |
| 2005 | Southwestern Medical Foundation Scholarship for Academic Achievement |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Gerber DE, Rasco DW, Le P, Yan J, Dowell JE, Xie Y. Predictors and impact of second-line chemotherapy for advanced non-small cell lung Cancer in the United States: real-world considerations for maintenance therapy. J Thorac Oncol 6(2):365-71, 2011. PMID: 21173713.
Abstracts
- Le P, Law JY, Dao BD, Ahn C, Kumar K, Anderson LD, Collins R, Li HC, Patel PA, Sadeghi N, Vusirikala M,Scaglioni PP, Naina HV. Treatment of adolescent young adults with acute lymphoblastic leukemia: 10-year outcome data from single institution. J Clin Oncol 2015;American Society of Clinical Oncology (ASCO), May 2015, Chicago, IL 33(15), 2015.
- Dao BD, Law JY, Le P, Ahn C, Kumar K, Anderson LD, Collins R, Li HC, Patel PA, Sadeghi N, Vusirikala M,Scaglioni PP, Naina HV. Clinical outcome of adult acute lymphoblastic leukemia based on Philadelphia chromosome status and socioeconomic status. J Clin Oncol 2015; American Society of Clinical Oncology (ASCO), May 2015, Chicago, IL 33(15), 2015.
- Law JY, Dao BD, Le P, Ahn C, Kumar K, Anderson LD, Collins R, Li HC, Patel PA, Sadeghi N, Vusirikala M,Scaglioni PP, Naina HV. Impact of body mass index and ethnicity on asparaginase toxicity in adult acute lymphoblastic leukemia patients. J Clin Oncol 2015; American Society of Clinical Oncology (ASCO), May 2015, Chicago, IL 33(15), 2015.
Book Chapters
- Ramzan Z, Le P, Kapur P, Huerta S.. Current Concepts in Pancreatic Cancer. In: Updates on Cancer Treatment, Prof. Leticia Rangel (Ed.). In TECH, 2015.